Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
18FDG-PET scan
DIAGNOSTIC_TEST
2 trials
Sponsors
National Cancer Institute (NCI)
, Assistance Publique - Hôpitaux de Paris
Conditions
B-Cell Neoplasm
Idiopathic Pulmonary Fibrosis
Primary Effusion Lymphoma
Phase 1
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Active, not recruiting
NCT02911142
National Cancer Institute (NCI)
B-Cell Neoplasm, Primary Effusion Lymphoma
Start: 2017-07-03
End: 2027-10-01
Updated: 2025-07-28
Unknown Phase
Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone
NCT03692481
Assistance Publique - Hôpitaux de Paris
Idiopathic Pulmonary Fibrosis
Start: 2020-02-04
End: 2024-04-30
Target: 50
Updated: 2022-10-04
Related Papers
Distinct immune profiles among patients with primary effusion lymphoma and other kaposi sarcoma herpesvirus-associated diseases
Blood
2025-11-03